[Glutathione S-transferase isoenzymes] [PMID: 3074377] Laboratory literature summary: [Glutathione S-transferase isoenzymes]
& Carnell, S
Compounded semaglutide and compounded tirzepatide have become increasingly popular because they are often: more affordable easier to access available through telehealth programs offered in customized dosing schedules Many people explore compounded options when insurance does not cover brand-name medications or when the cost of brand-name products is prohibitive
While clinical evidence 52,53 has indicated a possible elevated risk, causality has not been established
Pigmentation and melanosis (melanotic macules) may occur for a variety of reasons and may appear in multiple or single locations in the mouth and also on the lips

Key factors influencing dose selection include: Treatment goals : Whether the primary aim is glycaemic control, weight reduction, or cardiovascular risk reduction Baseline HbA1c and blood glucose levels : Higher values may eventually require higher maintenance doses Body weight and BMI : Particularly relevant for weight management indications Renal function : Most GLP-1 medications (semaglutide, liraglutide, dulaglutide) do not require dose adjustment for kidney impairment, but exenatide and lixisenatide should be used with caution or avoided in severe renal impairment Concurrent medications : Especially other glucose-lowering agents that might increase hypoglycaemia risk Previous medication tolerance : History of gastrointestinal sensitivity influences titration speed Cardiovascular history : Some GLP-1 medications have proven cardiovascular benefits at specific doses Diabetic retinopathy status : Rapid improvement in blood glucose can temporarily worsen retinopathy, particularly with semaglutide [22] [23] Your doctor will typically schedule regular follow-up appointments during the initial months of treatment
